New Developments in the Pharmacotherapy of Alcohol Dependence
Authors:
- 1 January 2001
- journal article
- review article
- Published by Wiley in The American Journal on Addictions
- Vol. 10 (s1) , s3-s15
Abstract
Neuroscientific underpinnings and pharmacotherapeutic treatments of sub‐stance use disorders are rapidly developing areas of study. In particular, there have been exciting new developments in our understanding of the involvement of excitatory amino acid neurotransmitter systems and the opiate and serotonin systems in the pathophysiology of alcohol withdrawal, alcohol dependence, and in subtypes of individuals with alcoholism. In this article, new developments in the pharmacotherapy of alcohol dependence will be reviewed. In particular, the use of anticonvulsants in alcohol withdrawal and protracted abstinence syndromes will be discussed. New data on opiate antagonists and acamprosate, an agent that exerts actions through excitatory amino acid systems in relapse prevention, will be reviewed. Finally, there will be a review of new data concerning the use of serotonin reuptake inhibitors in subtypes of alcoholism and the use of combination pharmacotherapy.Keywords
This publication has 66 references indexed in Scilit:
- The Effect of Drinking Intensity and Frequency on Serum Carbohydrate‐Deficient Transferrin and γ‐ Glutamyl Transferase Levels in Outpatient AlcoholicsAlcohol, Clinical and Experimental Research, 1998
- A Pilot Open Randomized Trial of Valproate and Phenobarbital in the Treatment of Acute Alcohol WithdrawalThe American Journal on Addictions, 1998
- The Serotonin Reuptake Inhibitor Sertraline Reduces Excessive Alcohol Consumption in Nonhuman Primates: Effect of StressNeuropsychopharmacology, 1998
- Acamprosate treatment in a long‐term community‐based alcohol rehabilitation programmeAddiction, 1997
- AcamprosateDrugs, 1997
- Efficacy of Buspirone in Alcohol Dependence: A ReviewAlcohol, Clinical and Experimental Research, 1996
- Alterations in serotonin1B (5HT1B) receptor subtypes in the brain of ethanol-treated ratsDrug and Alcohol Dependence, 1996
- Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholicsInternational Clinical Psychopharmacology, 1996
- Citalopram in the Treatment of Alcoholism: a Double-blind Placebo-controlled StudyPharmacopsychiatry, 1996
- Comparative Effectiveness and Costs of Inpatient and Outpatient Detoxification of Patients with Mild-to-Moderate Alcohol Withdrawal SyndromeNew England Journal of Medicine, 1989